'Moreover, it was revealed that the complex of YAP1, CLDN4, and zona occludens-2 was formed by CPE treatment, further suppressing YAP1 phosphorylation by LATS1 and activating it.' Oncotarget Volume 11 ...
Supra-additive effect of IMO-4200, a novel TLR7 and TLR8 dual agonist, with rituximab and cytotoxics in preclinical models of hematologic malignancies. This is an ASCO Meeting Abstract from the 2011 ...
The first step of toxin activity is the recognition of a specific receptor on the target cell surface. When bound to the receptor, toxins can act at the cell membrane by interfering with signal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results